TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,669,115,000 | +210.8% | 48,759 | +10.9% | 0.00% | +100.0% |
| Q1 2022 | $1,180,407,000 | -43.7% | 43,963 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,097,035,000 | -29.7% | 43,963 | -2.1% | 0.00% | 0.0% |
| Q3 2021 | $2,983,304,000 | -14.2% | 44,909 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $3,478,678,000 | -13.3% | 44,587 | +5.1% | 0.00% | -50.0% |
| Q1 2021 | $4,014,210,000 | -10.1% | 42,438 | +15.8% | 0.00% | 0.0% |
| Q4 2020 | $4,467,143,000 | +80.3% | 36,661 | +29.3% | 0.00% | +100.0% |
| Q3 2020 | $2,477,617,000 | +31.9% | 28,361 | -2.5% | 0.00% | 0.0% |
| Q2 2020 | $1,878,471,000 | +342.8% | 29,083 | +206.1% | 0.00% | – |
| Q1 2020 | $424,270,000 | -53.6% | 9,500 | -35.3% | 0.00% | -100.0% |
| Q4 2019 | $914,293,000 | – | 14,678 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |